SCHEMBL5772798

SCHEMBL5772798

CCC(C)OC(=O)C(C(=O)O)c1nc(Cl)ncc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
XBP1 P17861 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TLR9 Q9NR96 1/20 0.32
STK17B O94768 1/20 0.31
STK17A Q9UEE5 1/20 0.31
GABRA1 P14867 3/20 0.31
GABRG2 P18507 3/20 0.31
GABRB3 P28472 3/20 0.31
GABRA5 P31644 3/20 0.31
GABRA3 P34903 3/20 0.31
GABRA2 P47869 3/20 0.31
GABRA6 Q16445 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL940332 0.80 MAPK1 (0.40) MAPTALDH1A1MAPK1GABRA1GABRG2
SCHEMBL18335086 0.78 MAPK1 (0.38) MAPTMAPK1NPSR1HSD17B10GABRA1
SCHEMBL4534445 0.77 MAPT (0.37) MAPTGABRA1GABRG2GABRB3GABRA5
SCHEMBL17476583 0.77 MAPT (0.40) MAPTALDH1A1NPC1TP53HTT
SCHEMBL5772792 0.76 MEN1 (0.44) MAPTALDH1A1TDP1NPC1TP53
SCHEMBL5309259 0.73 MAPT (0.36) MAPT
SCHEMBL12985302 0.72 MAPT (0.38) MAPTGABRA1GABRG2GABRB3GABRA5
SCHEMBL15142139 0.72 ALDH1A1 (0.36) MAPTALDH1A1TDP1TP53MAPK1
SCHEMBL2654654 0.71 MAPT (0.39) MAPTALDH1A1NPC1STING1MEN1
SCHEMBL7691831 0.71 MAPT (0.43) MAPTALDH1A1NPC1TP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006066899-A1 NOVEL THROMBIN INHIBITORS SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2006-06-29 WO disclosed
EP-1674464-A1 Novel thrombin inhibitors Santhera Pharmaceuticals (Schweiz) GmbH (CH) 2006-06-28 EP disclosed